cyc 202 has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Airik, M; Airik, R; Conlon, PJ; Dorman, A; Huynh, AB; McCourt, BT; Murray, SL; Phua, YL; Rush, BM; Tan, RJ; Vockley, J | 1 |
| Haylor, J; Khwaja, A; Nutter, F | 1 |
2 other study(ies) available for cyc 202 and Chronic Kidney Diseases
| Article | Year |
|---|---|
Persistent DNA damage underlies tubular cell polyploidization and progression to chronic kidney disease in kidneys deficient in the DNA repair protein FAN1.
Topics: Animals; DNA Damage; DNA Repair; Endodeoxyribonucleases; Exodeoxyribonucleases; Fibrosis; Humans; Kidney; Mice; Mice, Knockout; Multifunctional Enzymes; Nephritis, Interstitial; Renal Insufficiency, Chronic; Roscovitine | 2022 |
Seliciclib inhibits renal hypertrophy but not fibrosis in the rat following subtotal nephrectomy.
Topics: Albuminuria; Animals; Cyclin A1; Cyclin-Dependent Kinase 2; Disease Progression; Extracellular Matrix; Fibrosis; Glomerulosclerosis, Focal Segmental; Hypertension; Hypertrophy; Kidney; Nephrectomy; Purines; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Roscovitine | 2012 |